AIM ImmunoTech Reports Positive Topline Results from Phase :

Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety results show Ampligen is...

Related Keywords

United States , American , Chris Mcaleer , Thomask Equels , Exchange Commission , Facebook , Linkedin , Immunotech Inc , Twitter , Company Phase , Fatigue Score , Six Minute Walk Test , Executive Officer Thomas , Officer Chris Mcaleer , Private Securities Litigation Reform Act , Nyse Aim , Aim Immunotech Inc , Covid 19 , Long Covid , Ampligen , Intatolimod ,